DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
for Small Cell Lung Cancer (SCLC)
Drug: Atezolizumab
14 locations incl. Mobile
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07472517·Phase 3·Recruiting